Literature DB >> 19561423

Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children.

Valerie Waters1, Frances Jamieson, Susan E Richardson, Michael Finkelstein, Anne Wormsbecker, Scott A Halperin.   

Abstract

BACKGROUND: From October 2005 to March 2006, a laboratory-confirmed outbreak of pertussis occurred in preschool-aged children (1-4 years) in Toronto, Canada. A case-control study in children was done to identify the risk factors for being positive for Bordetella pertussis by polymerase chain reaction (PCR).
METHODS: A case was defined as an individual 0 to 18 years of age who tested positive for B. pertussis by PCR in Toronto from October 2005 to March 2006. Each case was matched to 2 controls (negative for B. pertussis by PCR) by: (1) age, (2) geographic region of testing, and (3) date of testing.
RESULTS: One hundred eighty-nine cases and 296 controls were enrolled. Only 42% of cases (vs. 25% controls, P < 0.0001) met a clinical definition of pertussis, 3 cases (4 controls) were hospitalized, and the secondary household attack rate was 8%. One-third of cases were positive for another respiratory pathogen and >90% of cases and controls were up-to-date with pertussis immunization. Children attending school (matched odds ratio [ORm] = 5.2; 95% confidence intervals [CI]: 1.4-19.0), day care (ORm = 2.2; 95% CI: 1.2-4.0), visiting a doctor's office (ORm = 1.6; 95% CI: 1.0-2.5), or exposed to a household member (median age: 4-5 years) with a pertussis-like cough (ORm = 1.9; 95% CI: 1.0-3.6) were significantly more likely to have a positive PCR test for B. pertussis.
CONCLUSIONS: The main risk factors for PCR positivity for B. pertussis were school or day care attendance. Atypical symptoms were likely moderated by high immunization rates or may have been caused by other respiratory pathogens. In some cases, a positive PCR result might simply have reflected transient nasopharyngeal carriage of B. pertussis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19561423     DOI: 10.1097/INF.0b013e318197fac1

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

Review 1.  Emerging technologies for the clinical microbiology laboratory.

Authors:  Blake W Buchan; Nathan A Ledeboer
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Time since last vaccine dose in PCR-positive and PCR-negative children with suspected pertussis to monitor pertussis vaccine effectiveness.

Authors:  M Riffelmann; J Mohr; W Hellenbrand; C H Wirsing von Koenig
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-01       Impact factor: 3.267

3.  Using a bayesian latent class model to evaluate the utility of investigating persons with negative polymerase chain reaction results for pertussis.

Authors:  Gillian A M Tarr; Jens C Eickhoff; Ruth Koepke; Daniel J Hopfensperger; Jeffrey P Davis; James H Conway
Journal:  Am J Epidemiol       Date:  2013-06-04       Impact factor: 4.897

4.  Should equivocal Bordetella pertussis PCR results in children be reported to public health?

Authors:  M Desjardins; S Mousseau; P Doyon-Plourde; N Brousseau; D Iachimov; F Rallu; C Quach
Journal:  Can Commun Dis Rep       Date:  2018-09-06

5.  Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modeling.

Authors:  David N Fisman; Patrick Tang; Tanya Hauck; Susan Richardson; Steven J Drews; Donald E Low; Frances Jamieson
Journal:  BMC Public Health       Date:  2011-09-07       Impact factor: 3.295

6.  Exploring the reasons for low pertussis vaccine effectiveness in Ontario, Canada, 2006-2008: a Canadian Immunization Research Network study.

Authors:  Stephanie L Hughes; Jeffrey C Kwong; Kevin L Schwartz; Cynthia Chen; Caitlin Johnson; Ye Li; Alex Marchand-Austin; Shelly Bolotin; Frances B Jamieson; Steven J Drews; Margaret L Russell; Lawrence W Svenson; Salaheddin M Mahmud; Natasha S Crowcroft
Journal:  Can J Public Health       Date:  2021-08-23

7.  Validation of infant immunization billing codes in administrative data.

Authors:  Kevin L Schwartz; Karen Tu; Laura Wing; Michael A Campitelli; Natasha S Crowcroft; Shelley L Deeks; Sarah E Wilson; Kumanan Wilson; Ian Gemmill; Jeffrey C Kwong
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Correlation of Real Time PCR Cycle Threshold Cut-Off with Bordetella pertussis Clinical Severity.

Authors:  Shelly Bolotin; Shelley L Deeks; Alex Marchand-Austin; Heather Rilkoff; Vica Dang; Ryan Walton; Ahmed Hashim; David Farrell; Natasha S Crowcroft
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 9.  Pertussis. A reemerging and an underreported infectious disease.

Authors:  Muhammad A Syed; Noureen F Bana
Journal:  Saudi Med J       Date:  2014-10       Impact factor: 1.484

10.  Does working in hospital increases seroprevalence and carrier state against Bordetella pertussis?

Authors:  Alireza Emami Naeini; Nasim Zaman; Farzin Khorvash; Sahar Emami Naeini; Hesam-Al-Din Khodadadi; Mojgan Mokhtari; Ali Mehrabi Koushki
Journal:  Adv Biomed Res       Date:  2015-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.